GLA and Fabry disease: In Fabry disease therapy, the researchers investigated adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA (AAV2/6hGLA), an adeno-associated virus (AAV)-based gene therapy vector recently (94).